Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 20/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl(Trityl)Sulfane SCHEMBL4755270 | 0.86 | KIF11 (0.56) | KIF11 | |
| SCHEMBL13741458 | 0.86 | KIF11 (0.74) | KIF11 | |
| SCHEMBL18599373 | 0.85 | KIF11 (0.57) | KIF11 | |
| SCHEMBL4613838 | 0.84 | KIF11 (0.72) | KIF11 | |
| Ethyl(Trityl)Sulfane SCHEMBL2772809 | 0.84 | KIF11 (0.54) | KIF11 | |
| SCHEMBL6909006 | 0.84 | KIF11 (0.55) | KIF11 | |
| SCHEMBL26224 | 0.84 | KIF11 (0.55) | KIF11 | |
| Ethyl(Trityl)Sulfane SCHEMBL16908567 | 0.82 | KIF11 (0.52) | KIF11 | |
| SCHEMBL4616348 | 0.82 | KIF11 (0.55) | KIF11 | |
| SCHEMBL12086374 | 0.78 | KIF11 (0.54) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3947347-A1 | PANTETHENOYLCYSTEINE DERIVATIVES AND USES THEREOF | Comet Therapeutics, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| EP-3394185-B1 | NOVEL COMPOSITIONS AND USE THEREOF FOR MODIFICATION OF SUBSTRATE SURFACES | MERCK PATENT GMBH (DE) | 2020-12-09 | — | — | EP | disclosed |
| WO-2020198573-A1 | PANTETHENOYLCYSTEINE DERIVATIVES AND USES THEREOF | COMET THERAPEUTICS, INC. (US) | 2020-10-01 | — | — | WO | disclosed |
| US-9821072-B2 | Activated neurotensin molecules and the uses thereof | VECT-HORUS (FR) | 2017-11-21 | — | — | US | disclosed |
| US-20170174931-A1 | NOVEL COMPOSITIONS AND USE THEREOF FOR MODIFICATION OF SUBSTRATE SURFACES | AZ ELECTRONIC MATERIALS (LUXEMBOURG) S.A.R.L. (LU) | 2017-06-22 | — | — | US | disclosed |
| WO-2017068596-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF (1S, 4S, 7Z, 10S, 16E, 21R)- 7-ETHYLIDENE-4,21-BIS(1-METHYLETHYL)-2-OXA-12,13-DITHIA-5, 8, 20, 23- TETRAAZABICYCLO[8.7.6]TRICOS-16-ENE-3, 6, 9, 19, 22-PENTONE | MSN LABORATORIES PRIVATE LIMITED (IN) | 2017-04-27 | — | — | WO | disclosed |
| US-20160354480-A1 | ACTIVATED NEUROTENSIN MOLECULES AND THE USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-12-08 | — | — | US | disclosed |
| US-20160354480-A1 | ACTIVATED NEUROTENSIN MOLECULES AND THE USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-12-08 | — | — | US | disclosed |
| WO-2015120287-A2 | COMPOSITIONS AND METHODS OF USE THEREOF FOR MAKING POLYPEPTIDES WITH MANY INSTANCES OF NONSTANDARD AMINO ACIDS | YALE UNIVERSITY (US) | 2015-08-13 | — | — | WO | disclosed |
| US-8609857-B2 | Poly(ethylene glycol) containing chemically disparate endgroups | INTEZYNE TECHNOLOGIES, INC. (US) | 2013-12-17 | — | — | US | disclosed |
| US-20100160645-A1 | POLY(ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS | INTEZYNE TECHNOLOGIES, INC. (US) | 2010-06-24 | — | — | US | disclosed |
| US-7560588-B2 | Poly(ethylene glycol) containing chemically disparate endgroups | INTEZYNE TECHNOLOGIES, INC. (US) | 2009-07-14 | — | — | US | disclosed |
| US-7560588-B2 | Poly(ethylene glycol) containing chemically disparate endgroups | INTEZYNE TECHNOLOGIES, INC. (US) | 2009-07-14 | — | — | US | disclosed |
| US-20080207913-A1 | Poly(ethylene glycol) containing chemically disparate endgroups | INTEZYNE TECHNOLOGIES (US) | 2008-08-28 | — | — | US | disclosed |
| US-20080207913-A1 | Poly(ethylene glycol) containing chemically disparate endgroups | INTEZYNE TECHNOLOGIES (US) | 2008-08-28 | — | — | US | disclosed |
| WO-2007127473-A2 | POLY (ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS | INTEZYNE TECHNOLOGIES, INC. (US) | 2007-11-08 | — | — | WO | disclosed |
| EP-0482185-A4 | CELL INTERNALIZABLE CONJUGATES AND COMPLEXES INCLUDING INTRACELLULARLY CLEAVABLE MOIETIES | BIOSPAN CORP (US) | 1995-05-17 | — | — | EP | disclosed |
| EP-0587440-A2 | Catalyst component for the polymerisation of olefins and process for preparing olefin polymers using same | NIPPON OIL COMPANY, LIMITED (JP) | 1994-03-16 | — | — | EP | disclosed |
| EP-0482185-A1 | CELL INTERNALIZABLE CONJUGATES AND COMPLEXES INCLUDING INTRACELLULARLY CLEAVABLE MOIETIES | ANERGEN, INC. (US) | 1992-04-29 | — | — | EP | disclosed |
| WO-1991018012-A1 | CELL INTERNALIZABLE CONJUGATES AND COMPLEXES INCLUDING INTRACELLULARLY CLEAVABLE MOIETIES | BIOSPAN CORPORATION (US) | 1991-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160645-A1 | POLY(ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS | GNE, EPRS1, ALG1 | KIF11 2303/4885 |
| US-20160354480-A1 | ACTIVATED NEUROTENSIN MOLECULES AND THE USES THEREOF | NTSR2, NTSR1, NTRK2 | KIF11 1829/4885 |
| US-20080207913-A1 | Poly(ethylene glycol) containing chemically disparate endgroups | GNE, EPRS1, ALG1 | KIF11 2303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.